162 related articles for article (PubMed ID: 30378041)
1. Develop Nomogram to Predict Malignancy of Intraductal Papillary Mucinous Neoplasm.
Kim Y; Park T
Methods Mol Biol; 2019; 1882():23-32. PubMed ID: 30378041
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
3. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract][Full Text] [Related]
4. External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model.
Casadei R; Ricci C; Ingaldi C; Cornacchia A; Migliori M; Di Marco M; Pagano N; Serra C; Alberici L; Minni F
Updates Surg; 2021 Apr; 73(2):429-438. PubMed ID: 33620642
[TBL] [Abstract][Full Text] [Related]
5. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Jang JY; Park T; Lee S; Kim Y; Lee SY; Kim SW; Kim SC; Song KB; Yamamoto M; Hatori T; Hirono S; Satoi S; Fujii T; Hirano S; Hashimoto Y; Shimizu Y; Choi DW; Choi SH; Heo JS; Motoi F; Matsumoto I; Lee WJ; Kang CM; Han HS; Yoon YS; Sho M; Nagano H; Honda G; Kim SG; Yu HC; Chung JC; Nagakawa Y; Seo HI; Yamaue H
Ann Surg; 2017 Dec; 266(6):1062-1068. PubMed ID: 27607098
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
Sereni E; Luchini C; Salvia R; Pea A
Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
[TBL] [Abstract][Full Text] [Related]
7. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Al Efishat MA; Attiyeh MA; Eaton AA; Gönen M; Prosser D; Lokshin AE; Castillo CF; Lillemoe KD; Ferrone CR; Pergolini I; Mino-Kenudson M; Rezaee N; Dal Molin M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; Kingham TP; DeMatteo RP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Aug; 268(2):340-347. PubMed ID: 28700444
[TBL] [Abstract][Full Text] [Related]
8. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.
Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Kanemitsu Y; Sano T; Senda Y; Bhatia V; Yanagisawa A
Pancreas; 2015 Apr; 44(3):459-64. PubMed ID: 25423557
[TBL] [Abstract][Full Text] [Related]
9. Natural history and optimal treatment strategy of intraductal papillary mucinous neoplasm of the pancreas: Analysis using a nomogram and Markov decision model.
Han Y; Jang JY; Oh MY; Kim HS; Byun Y; Kang JS; Kim SH; Lee KB; Kim H; Kwon W
J Hepatobiliary Pancreat Sci; 2021 Feb; 28(2):131-142. PubMed ID: 33283481
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made?
Lim J; Allen PJ
Updates Surg; 2019 Jun; 71(2):209-216. PubMed ID: 31175628
[TBL] [Abstract][Full Text] [Related]
11. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
12. Nomograms predicting long-term survival in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: A population-based study.
Wu JY; Wang YF; Ma H; Li SS; Miao HL
World J Gastroenterol; 2020 Feb; 26(5):535-549. PubMed ID: 32089629
[TBL] [Abstract][Full Text] [Related]
13. Increased hardness of the underlying pancreas correlates with the presence of intraductal papillary-mucinous neoplasm in a limited number of cases.
Koya T; Kawashima H; Ohno E; Ishikawa T; Ishigami M; Hashimoto S; Goto H; Hirooka Y
J Med Ultrason (2001); 2019 Oct; 46(4):441-447. PubMed ID: 31218473
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas.
Fang X; Liu F; Li J; Cao K; Wang T; Zhang H; Li Q; Meng Y; Yu J; Feng X; Jiang H; Wang L; Lu J; Shao C; Bian Y
Abdom Radiol (NY); 2021 Nov; 46(11):5218-5228. PubMed ID: 34409514
[TBL] [Abstract][Full Text] [Related]
15. Multilocular Cyst of Type 1 Autoimmune Pancreatitis Masquerading as Cancerization of Intraductal Papillary Mucinous Neoplasm.
Kaneko J; Matsubayashi H; Satoh T; Sato J; Takinami M; Ishiwatari H; Uesaka K; Abe M; Sasaki K; Ono H
Intern Med; 2020 Jan; 59(2):199-204. PubMed ID: 31484912
[TBL] [Abstract][Full Text] [Related]
16. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
17. Circulating Leptin and Branched Chain Amino Acids-Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade.
Yip-Schneider MT; Simpson R; Carr RA; Wu H; Fan H; Liu Z; Korc M; Zhang J; Schmidt CM
J Gastrointest Surg; 2019 May; 23(5):966-974. PubMed ID: 30215202
[TBL] [Abstract][Full Text] [Related]
18. Analyzing and predicting the LNM rate and prognosis of patients with intraductal papillary mucinous neoplasm of the pancreas.
Tang CT; Liu BX; Chen Y; Zeng C
Cancer Med; 2021 Mar; 10(6):1925-1935. PubMed ID: 33641255
[TBL] [Abstract][Full Text] [Related]
19. Rapid growth speed of cysts can predict malignant intraductal mucinous papillary neoplasms.
Akahoshi K; Ono H; Akasu M; Ban D; Kudo A; Konta A; Tanaka S; Tanabe M
J Surg Res; 2018 Nov; 231():195-200. PubMed ID: 30278929
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process.
Buscail E; Cauvin T; Fernandez B; Buscail C; Marty M; Lapuyade B; Subtil C; Adam JP; Vendrely V; Dabernat S; Laurent C; Chiche L
BMC Surg; 2019 Aug; 19(1):115. PubMed ID: 31438917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
